SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-053461
Filing Date
2022-10-12
Accepted
2022-10-12 16:21:30
Documents
2
Period of Report
2022-10-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1652
2 POA DOCUMENT poa.txt EX-24 3601
  Complete submission text file 0001209191-22-053461.txt   6704
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address
Attar Eyal C. (Reporting) CIK: 0001789076 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39979 | Film No.: 221307059

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)